journal
MENU ▼
Read by QxMD icon Read
search

JACC. Heart Failure

journal
https://www.readbyqxmd.com/read/27816512/prognostic-value-of-soluble-suppression-of-tumorigenicity-2-in-chronic-heart-failure-a-meta-analysis
#1
Alberto Aimo, Giuseppe Vergaro, Claudio Passino, Andrea Ripoli, Bonnie Ky, Wayne L Miller, Antoni Bayes-Genis, Inder Anand, James L Januzzi, Michele Emdin
OBJECTIVES: The purpose of this study was to perform the first meta-analysis of currently available data. BACKGROUND: Soluble suppression of tumorigenesis 2 (sST2) plasma concentration is elevated in chronic heart failure (CHF) and helps to predict prognosis in this setting, although the evidence is limited. METHODS: Three databases (Medline, Cochrane Library, and Scopus) were searched. Inclusion criteria were: follow-up studies; papers published in English; enrollment of CHF outpatients; available data on hazard ratio (HR) for the log2 ST2 (so that the reported HRs represent the risk per doubling of sST2) and 95% confidence interval (CI) for all-cause death, and possibly also for cardiovascular (CV) death; and use of standardized sST2 assay...
October 27, 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27816511/does-small-size-matter-with-continuous%C3%A2-flow-devices-analysis-of-the-intermacs-database-of-adults-with-bsa%C3%A2-%C3%A2-1-5-m-2
#2
Farhan Zafar, Chet R Villa, David L Morales, Elizabeth D Blume, David N Rosenthal, James K Kirklin, Angela Lorts
OBJECTIVES: This study investigated how small patient size affects clinical outcomes in patients implanted with a continuous flow left ventricular assist device (CFLVAD). BACKGROUND: The development of smaller CFLVADs has allowed ventricular assist device (VAD) use in anatomically smaller patients; however, limited outcome data exist regarding CFLVAD use in patients with a body surface area (BSA) ≤1.5 m(2). METHODS: All CFLVAD patients entered in the Interagency Registry for Mechanically Assisted Circulatory Support registry April 2008 to September 2013 and with BSA data were included...
October 27, 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27744089/insulin-like-growth-factor-binding-protein-7-as-a-biomarker-of-diastolic-dysfunction-and-functional-capacity-in-heart-failure-with-preserved-ejection-fraction-results-from-the-relax-trial
#3
Parul U Gandhi, Hanna K Gaggin, Margaret M Redfield, Horng H Chen, Susanna R Stevens, Kevin J Anstrom, Marc J Semigran, Peter Liu, James L Januzzi
OBJECTIVES: This study sought to investigate relationships between insulin-like growth factor-binding protein 7 (IGFBP7) and parameters of diastolic function or functional capacity in patients with heart failure and preserved ejection fraction (HFpEF) who were randomized to receive sildenafil or placebo. BACKGROUND: IGFBP7 was previously found to be associated with diastolic function in heart failure with reduced ejection fraction, but it is unclear whether these associations are present in HFpEF...
September 29, 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27908397/not-your-mother-s-fda
#4
EDITORIAL
Christopher M O'Connor
No abstract text is available yet for this article.
December 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27908396/the-fda-in-the-21st-century-how-is-the-fda-responding-to-the-new-world-a-focus-on-heart-failure-devices
#5
EDITORIAL
Matthew Hillebrenner, Bram Zuckerman, Mona Fiuzat, Norman Stockbridge, Robert Califf
No abstract text is available yet for this article.
December 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27908395/vad-why-does-it-bleed
#6
EDITORIAL
Martin Strueber
No abstract text is available yet for this article.
December 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27908394/whose-metric-is-it-anyway-time-for-patients-to-assert-quality-control
#7
EDITORIAL
Marvin A Konstam
No abstract text is available yet for this article.
December 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27908393/association-of-30-day-readmission-metric%C3%A2-for-heart-failure-under-the-hospital%C3%A2-readmissions-reduction-program%C3%A2-with-quality-of-care-and%C3%A2-outcomes
#8
Ambarish Pandey, Harsh Golwala, Haolin Xu, Adam D DeVore, Roland Matsouaka, Michael Pencina, Dharam J Kumbhani, Adrian F Hernandez, Deepak L Bhatt, Paul A Heidenreich, Clyde W Yancy, James A de Lemos, Gregg C Fonarow
OBJECTIVES: This study sought to determine whether processes of care and long-term clinical outcomes for heart failure (HF) admissions across Get With The Guidelines-Heart Failure (GWTG-HF) program participating centers differ according to HF-specific risk-adjusted 30-day readmission rates (excess readmission ratio [ERR]) as determined by the Hospital Readmission Reduction Program (HRRP). BACKGROUND: HRRP penalizes hospitals with higher than expected risk-adjusted 30-day readmission rates (ERR >1) for common conditions including HF...
December 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27908392/severe-obesity-and-acute-decompensated%C3%A2-heart-failure-new-insights-into-prevalence-and-prognosis
#9
EDITORIAL
Martin A Alpert
No abstract text is available yet for this article.
December 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27908391/prevalence-profile-and-prognosis-of-severe-obesity-in-contemporary-hospitalized-heart-failure-trial-populations
#10
Emer Joyce, Anuradha Lala, Susanna R Stevens, Lauren B Cooper, Omar F AbouEzzeddine, John D Groarke, Justin L Grodin, Eugene Braunwald, Kevin J Anstrom, Margaret M Redfield, Lynne W Stevenson
OBJECTIVES: This study evaluated the prevalence, profile, and prognosis of severe obesity in a large contemporary acute heart failure (AHF) population. BACKGROUND: Better prognosis has been reported for obese heart failure (HF) patients than nonobese HF patients, but in other cardiovascular populations, this effect has not been demonstrated for severely obese patients. METHODS: A cohort of 795 participants with body mass index (BMI) measured at time of admission and complete follow-up were identified from enrollment in 3 contemporary AHF trials (DOSE [Diuretic Strategies Optimization Evaluation], CARRESS-HF [Cardiorenal Rescue Study in Acute Decompensated Heart Failure], and ROSE [Renal Optimization Strategies Evaluation in Acute Heart Failure])...
December 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27908390/living-without-heart-failure-contemporary-concepts-in-prevention
#11
EDITORIAL
Thomas J Wang
No abstract text is available yet for this article.
December 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27908389/hypertension-obesity-diabetes-and%C3%A2-heart%C3%A2-failure-free-survival-the-cardiovascular-disease-lifetime-risk-pooling-project
#12
Faraz S Ahmad, Hongyan Ning, Jonathan D Rich, Clyde W Yancy, Donald M Lloyd-Jones, John T Wilkins
OBJECTIVES: This study was designed to quantify the relationship between the absence of heart failure risk factors in middle age and incident heart failure, heart failure-free survival, and overall survival. BACKGROUND: Quantification of years lived free from heart failure in the context of risk factor burden in mid-life may improve risk communication and prevention efforts. METHODS: We conducted a pooled, individual-level analysis sampling from communities across the United States as part of 4 cohort studies: the Framingham Heart, Framingham Offspring, Chicago Heart Association Detection Project in Industry, and ARIC (Atherosclerosis Risk In Communities) studies...
December 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27816510/learning-from-our-predictions-the-heartmate-risk-score-in-intermacs
#13
EDITORIAL
Garrick C Stewart
No abstract text is available yet for this article.
December 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27744088/association-of-nasal-mucosal-vascular-alterations-gastrointestinal-arteriovenous-malformations-and-bleeding-in-patients%C3%A2-with-continuous-flow-left%C3%A2-ventricular-assist-devices
#14
Snehal R Patel, Shivank Madan, Omar Saeed, Mohammed Algodi, Anne Luke, Marc Gibber, Daniel J Goldstein, Ulrich P Jorde
OBJECTIVES: This study sought to determine whether the nasal mucosa can serve as a surrogate for evaluating arteriovenous malformations (AVMs) related gastrointestinal (GI) bleeding in patients supported by continuous-flow left ventricular assist devices (CF LVADs). BACKGROUND: Bleeding from the mucosal surfaces of GI tract, particularly AVMs, is the most common complication of CF LVAD support. The pathophysiology of AVM formation during CF LVAD support is of critical interest yet poorly understood; in large part because of the length and accessibility of the GI tract...
December 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27614939/the-heartmate-risk-score-identifies-patients-with-similar-mortality-risk-across%C3%A2-all-intermacs-profiles-in-a%C3%A2-large%C3%A2-multicenter-analysis
#15
Luigi Adamo, Yuanyuan Tang, Michael E Nassif, Eric Novak, Philip G Jones, Shane LaRue, John A Spertus, Douglas L Mann
OBJECTIVES: This study sought to assess the performance of the HeartMate Risk Score (HMRS) in a large multicenter cohort, with a focus on its performance as a function of disease severity. BACKGROUND: The HMRS has been proposed as a simple tool for risk stratification of LVAD recipients, but subsequent studies have challenged its validity. METHODS: We performed a retrospective, longitudinal, comparative study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) database...
December 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27810084/sitagliptin-and-risk-of-heart-failure-in-patients-with-type-2-diabetes-a-meta-analysis
#16
LETTER
Chayakrit Krittanawong, Takeshi Kitai, Mehmet Aydar, Tao Sun
No abstract text is available yet for this article.
November 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27810083/recovery-kinetics-there-is-nothing-new-except-what-has-been%C3%A2-forgotten
#17
LETTER
Georgios S Tzanis, Stavros K Dimopoulos, Serafim N Nanas
No abstract text is available yet for this article.
November 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27810082/peer-review-of-peer-review-somewhere-over-the-rainbow
#18
EDITORIAL
Christopher M O'Connor
No abstract text is available yet for this article.
November 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27810081/left-bundle-branch-block-is-it-unsafe-at-any-speed
#19
EDITORIAL
Edward Sze, James P Daubert
No abstract text is available yet for this article.
November 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/27810080/oral-anticoagulant-agents-in-patients-with%C3%A2-atrial-fibrillation-and-heart-failure-does-heart-failure-status-influence-efficacy-and-safety
#20
EDITORIAL
Faiez Zannad, João Pedro Ferreira
No abstract text is available yet for this article.
November 2016: JACC. Heart Failure
journal
journal
47572
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"